Skip to content

TrumpRx Drug Prices: Every Presidential Deals Medication

GovFacts
40 references across 8 domains
Government and agencies 19 Organizations and advocacy 17

Last updated 1 week ago. Our resources are updated regularly but please keep in mind that links, programs, policies, and contact information do change.

TrumpRx is a government-operated website where people can search for discounted prices on brand-name medicines when paying without using insurance. It advertises Plavix for $15.95 with a 98 percent discount. On the Plavix product page, it tells insured patients to check their copay first; it may be lower. The discount compares the offer with a manufacturer’s list price, not with the patient’s own price.

The table below lists the offers the site labels ‘Presidential deals,’ with the cash offer, list price and advertised discount shown on September 25, 2026. For any medicine in the catalog, the useful question is what the exact prescription would cost through each available route.

What the advertised discount measures

KFF, the health policy research group, explains that the site’s advertised savings use the manufacturer’s wholesale list price as the reference. That list price typically does not reflect what an insured consumer would have paid. A 90 percent discount can be substantial without being a 90 percent reduction in a particular family’s spending.

A TrumpRx product page describes its amount as an out-of-pocket price and asks the visitor to select a form, strength and quantity. For Protonix, the page changes the configuration across tablet or packet form, strength and pill count. The catalog’s ‘starting at’ number is an entry point; a selected prescription can produce a different offer. A meaningful comparison uses the same drug, form, strength and amount on both sides.

TrumpRx itself warns insured visitors that their copay may be lower than the displayed cash price. In KFF’s review published on February 24, 2026, about half of the listed drugs had generic equivalents, and at least three-quarters of those generics cost less through other cash-price routes than the TrumpRx coupon price for the brand. That review did not cover every medicine in the table below, but it shows why the brand-name offer should not end the search.

A patient should ask the pharmacist or prescriber whether an appropriate generic exists before switching a prescribed product. The Food and Drug Administration (FDA) advises people to discuss generic medicines with a doctor, pharmacist or other health care provider.

Every listing in the Presidential Deals catalog

The official browse page calls this group ‘Presidential deals,’ describes them as deals negotiated by President Trump for brand-name drugs and displayed 80 catalog listings when checked. The table below records that check, made on September 25, 2026, and is not a live price list. Offers and discounts vary widely: Humira Pen was listed at $950.00, while Relenza was listed at $52.90 against $59.00.

Presidential Deals catalog, checked September 25, 2026. “From” means the card says “Starting at.” The listed comparison price and discount are the catalog’s, not a patient quote. Extended release (XR) is a formulation label.
MedicineCash offerList priceAdvertised discount
Plavix®$15.95$771.6298 percent
Combigan®$10.00$204.1395 percent
Mayzent®From $41.23$623.0093 percent
Cetrotide®$22.50$316.1293 percent
Xigduo® XRFrom $45.00$599.7292 percent
Toujeo®From $35.00$428.5792 percent
Farxiga®From $35.00$377.8291 percent
Zeposia®From $925.00$9,060.7690 percent
Sotyktu®$743.00$7,135.5590 percent
Jentadueto®From $55.00$525.0890 percent
Jentadueto® XRFrom $55.00$525.0890 percent
Wegovy® PillFrom $149.00$1,349.0289 percent
Bevespi®$50.65$458.0589 percent
Striverdi® Respimat®$35.00$276.0087 percent
Humira® Pen$950.00$6,922.6286 percent
Humira® Prefilled SyringeFrom $950.00$6,922.6286 percent
Ozempic® PillFrom $149.00$1,027.5185 percent
Wegovy® PenFrom $199.00$1,349.0274 percent to 85 percent
Duavee®$30.30$202.0085 percent
Toviaz®From $43.50$290.0085 percent
Lovenox®From $11.90$74.4284 percent
Gonal-F®From $168.00$966.0483 percent
Ozempic® PenFrom $199.00$1,027.5166 percent to 81 percent
Eucrisa®$158.48$792.4080 percent
Amjevita®$299.00$1,484.1680 percent
Rydapt®From $2,908.64$13,411.0078 percent
Tabrecta®From $2,649.92$11,666.0077 percent
Foundayo™From $149.00$649.0077 percent
Alphagan® P$45.00$194.4477 percent
Janumet®From $84.57$330.0074 percent
Janumet® XRFrom $84.57$330.0074 percent
Januvia®From $84.57$330.0074 percent
Zepbound® VialFrom $299.00$1,087.0072 percent
Insulin Glargine (U-300)From $35.00$126.3372 percent
Xofluza®From $50.00$168.8370 percent
Airsupra®$156.63$503.9369 percent
Xarelto®From $197.00$611.8268 percent
Ovidrel®$84.00$251.8467 percent
Admelog®From $35.00$98.0764 percent
Synthroid®From $18.75$52.1164 percent
Enbrel®$3,353.93$9,177.3063 percent
Tresiba®From $35.00$94.2963 percent
Invokamet®From $225.00$598.5662 percent
Invokamet® XRFrom $225.00$598.5662 percent
Invokana®From $225.00$598.5662 percent
Aimovig®From $299.00$783.0262 percent
Repatha®$239.00$625.8962 percent
Prempro®From $98.84$254.3061 percent
Trulicity®From $389.00$987.1961 percent
Abrilada®From $207.60$519.0060 percent
Genotropin®From $89.67$224.1460 percent
Emgality®$299.00$741.6960 percent
Apidra®From $35.00$85.1959 percent
Praluent®From $225.00$537.2158 percent
Mounjaro®From $499.00$1,112.1655 percent
Incruse® Ellipta$159.20$354.1055 percent
Premarin®From $99.00$217.8655 percent
Pristiq®From $200.10$435.0054 percent
NovoLog®From $35.00$72.3452 percent
NovoLog® Mix 70/30From $35.00$72.3452 percent
Fiasp®From $35.00$71.6651 percent
Arnuity® ElliptaFrom $102.98$208.4951 percent
Colestid®From $67.20$135.6050 percent
Ngenla®From $2,217.00$4,434.2050 percent
Azulfidine®From $99.60$199.2050 percent
Azulfidine® EN-tabsFrom $130.80$261.6050 percent
Premarin® Vaginal Cream$236.65$473.3050 percent
Vfend®$306.98$613.9650 percent
Viracept®From $607.20$1,214.4050 percent
Zyvox®$122.74$245.4850 percent
Zavzpret®$594.84$1,189.6550 percent
Merilog™From $35.00$69.5750 percent
Anoro® Ellipta$247.94$489.0949 percent
Lantus®From $35.00$64.2646 percent
Zepbound® KwikPen®From $299.00$499.0040 percent
Otezla®$3,353.93$5,589.8940 percent
Orencia® SCFrom $3,660.00$6,070.5940 percent
Xeljanz®From $1,518.00$2,277.4333 percent
Priftin®$93.30$121.5523 percent
Relenza®$52.90$59.0010 percent
Insulin LisproFrom $25.00Not shownNot shown

In that check, the browse page listed Insulin Lispro starting at $25.00 and displayed no comparison price or discount percentage. A blank comparison field is not a zero discount; the site simply does not make that comparison on the card. Some catalog cards advertise a discount range, including the Wegovy pen and Ozempic pen. Open the product page and choose the actual prescription before treating any row as a quote.

Getting a deal from the screen to the pharmacy

TrumpRx functions as a search portal for discounted self-pay offers rather than a pharmacy that sells the medicines itself. For most of the medicines KFF examined, the site directed users to print a manufacturer coupon for use at a retail pharmacy. The route may look different for a drug handled through the manufacturer’s own direct-order channel. In either case, the catalog price is not a prescription or a guarantee that a pharmacy will have the product.

A valid prescription is required to buy every listed medicine. On a product page such as Protonix, visitors choose the form, strength and quantity before seeing the offer. The same page presents a coupon to show at a participating retail pharmacy. For Protonix, the official page says its coupon is widely supported at retail pharmacies that dispense the drug. A patient should confirm both the exact product and the final checkout price before paying.

Public Citizen, an advocacy group that argues the deals favor drug companies over patients, reviewed the released agreements and found that Pfizer and Eli Lilly did not write identical terms for patients in federal health programs. It says Pfizer’s disclosed text does not obligate it to offer covered products to people enrolled in a federal health care program through a platform that sells directly to patients.

The review says Lilly’s cash-price commitment for GLP-1 drugs, by contrast, covers patients regardless of insurance status, including government insurance. FDA describes GLP-1 receptor agonists as medicines used for type 2 diabetes or for weight loss in people with obesity or overweight. Eligibility for one manufacturer’s offer should not be assumed from another manufacturer’s card. Patients with Medicare or Medicaid should read the particular offer’s terms rather than assume the federal program will pay a TrumpRx transaction.

Insurance changes the comparison

KFF describes TrumpRx manufacturer coupons as self-pay transactions rather than purchases billed to private insurance. KFF says spending on such a coupon does not count toward a private plan’s deductible or out-of-pocket maximum. Money that counts toward a deductible can reduce what a patient owes for later covered care; by KFF’s account, money spent on a TrumpRx coupon does not count.

Part D is Medicare’s prescription-drug coverage. Medicare’s comparison tools let a person with Medicare enter prescription drugs and estimate monthly and annual plan costs. Medicare also has negotiated prices of its own: the Centers for Medicare and Medicaid Services (CMS) negotiated prices for selected Part D drugs that took effect on January 1, 2026. For a person with Part D, what matters is what the plan would charge for the drug compared with the cash offer, not which program advertises the bigger discount.

KFF reports that private insurers’ negotiated prices are often lower than the wholesale list price used in TrumpRx’s percentage calculation. KFF also notes that a discounted self-pay price may help an insured person who otherwise faces a high payment before meeting a deductible. The patient’s copay, deductible position, and any generic option have to be checked together.

What the government negotiated

The White House says President Donald Trump launched TrumpRx.gov on February 5, 2026. The administration says President Trump has announced deals with major pharmaceutical manufacturers to bring prices in line with those paid in other developed nations. The Peterson-KFF Health System Tracker is a collaboration between KFF and the Peterson Center on Healthcare that monitors U.S. healthcare quality and cost. A Peterson-KFF Health System Tracker analysis says the manufacturers whose drugs were on the site at launch had signed voluntary agreements with the White House, typically in exchange for tariff exemptions.

In an August 31, 2026 fact sheet, the White House claimed patients had saved more than $700 million through TrumpRx since its launch. That is the administration’s aggregate claim, not an estimate of what any one reader can save.

The Peterson-KFF analysis notes that questions have been raised about whether TrumpRx prices are lower than drug prices in other countries, as the website states. Its comparison found TrumpRx to be the lowest among peer-country prices for five of the 32 brand-name drugs it could compare.

Public Citizen’s review of released deal documents says Pfizer’s disclosed agreement ends on Jan. 20, 2029. The same review says the publicly released Lilly agreement redacts its termination provision. Public Citizen argues that redactions in the disclosed agreements obscure important prices and eligibility terms. The released documents do not establish when every catalog offer expires, so check the live offer terms to know whether a price still exists.

Before filling the prescription

The live TrumpRx site lets a visitor search the current brand-name offers and follow the listed coupon or manufacturer route. Check the exact strength and quantity on TrumpRx. If insured, compare the immediate cash price with the copay, any suitable generic, and how a self-pay fill would affect spending over the plan year.

Medicare’s own tools offer plan-cost estimates and links to pharmaceutical assistance programs for people with Medicare. Medicare says people meeting its income and resource limits may qualify for Extra Help with drug-coverage premiums, deductibles and copays. For Medicare or Medicaid coverage, ask the plan and the offer program how that particular purchase will be handled.

Our articles make government information more accessible. Please consult a qualified professional for financial, legal, or health advice specific to your circumstances.

Articles are now written and checked by the GovFacts Engine, an AI system. No government agency has any input into what it produces. Learn more about our article development and editing process.

We appreciate feedback from readers like you. If you want to suggest new topics or if you spot something that needs fixing, please contact us.